X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (16) 16
humans (10) 10
inflammation (10) 10
cytokines (8) 8
immunology (8) 8
female (7) 7
animals (6) 6
interleukins (6) 6
male (5) 5
mice (5) 5
proteins (5) 5
adult (4) 4
cytokine (4) 4
health aspects (4) 4
hyperoxia (4) 4
lung diseases (4) 4
abridged index medicus (3) 3
activation (3) 3
apoptosis (3) 3
autoimmune diseases (3) 3
bronchopulmonary dysplasia (3) 3
cell biology (3) 3
cells (3) 3
disease models, animal (3) 3
expression (3) 3
gene expression (3) 3
identification (3) 3
infants (3) 3
interleukin (3) 3
interleukin-1 (3) 3
leukocytes, mononuclear - immunology (3) 3
lipopolysaccharides - pharmacology (3) 3
lung - drug effects (3) 3
lupus (3) 3
lymphocytes (3) 3
mice, inbred c57bl (3) 3
multidisciplinary sciences (3) 3
physiological aspects (3) 3
pregnancy (3) 3
research (3) 3
research article (3) 3
rheumatoid-arthritis (3) 3
rodents (3) 3
t-lymphocytes - metabolism (3) 3
aged (2) 2
anti-inflammatory therapy (2) 2
article (2) 2
babies (2) 2
biochemistry & molecular biology (2) 2
biological sciences (2) 2
blood (2) 2
breast-cancer (2) 2
bronchopulmonary dysplasia - complications (2) 2
bronchopulmonary dysplasia - pathology (2) 2
cadherin missense mutations (2) 2
care and treatment (2) 2
cell culture (2) 2
cells, cultured (2) 2
dendritic cells (2) 2
disease (2) 2
enzyme-linked immunosorbent assay (2) 2
focal adhesion kinase (2) 2
genetics & heredity (2) 2
genomes (2) 2
growth (2) 2
histology (2) 2
host-defense (2) 2
hyperoxia - complications (2) 2
il-1 family (2) 2
il-1 receptor antagonist (2) 2
immunologic diseases. allergy (2) 2
in-vitro (2) 2
infant, newborn (2) 2
inflammation - complications (2) 2
inflammation - pathology (2) 2
innate inflammation (2) 2
interleukin 1 (2) 2
interleukin-1 - metabolism (2) 2
interleukin-22 (2) 2
interleukins - immunology (2) 2
interleukins - metabolism (2) 2
jurkat cells (2) 2
kinases (2) 2
leukocytes, mononuclear - drug effects (2) 2
lung - pathology (2) 2
lungs (2) 2
lyme disease (2) 2
macrophages (2) 2
medical research (2) 2
medicine (2) 2
medicine, research & experimental (2) 2
members (2) 2
microbiology (2) 2
middle aged (2) 2
model (2) 2
monocytes - drug effects (2) 2
monocytes - metabolism (2) 2
mortality (2) 2
mutation (2) 2
neonatal immunity (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 8/2013, Volume 110, Issue 35, pp. 14384 - 14389
Journal Article
Scientific Reports, ISSN 2045-2322, 10/2016, Volume 6, Issue 1, p. 34604
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by the development of autoantibodies to nuclear antigens and inflammatory... 
RHEUMATOID-ARTHRITIS | IN-VITRO | MEMBERS | INCREASED CCR4 EXPRESSION | MULTIDISCIPLINARY SCIENCES | CYTOKINE | INTERLEUKIN-10 | IDENTIFICATION | T-CELLS | DISEASE-ACTIVITY | FAMILY | Lupus | Systemic lupus erythematosus | Immunology | Cytokines | Health risk assessment | Autoimmune diseases
Journal Article
Journal of Leukocyte Biology, ISSN 0741-5400, 04/2017, Volume 101, Issue 4, pp. 901 - 911
Journal Article
Journal of Cellular and Molecular Medicine, ISSN 1582-1838, 06/2017, Volume 21, Issue 6, pp. 1128 - 1138
Bronchopulmonary dysplasia (BPD) is a severe lung disease of preterm infants, which is characterized by fewer, enlarged alveoli and increased inflammation. BPD... 
protein C | neonatal lung disease | hyperoxia | IL‐1 receptor antagonist | inflammation | IL-1 receptor antagonist | MEDICINE, RESEARCH & EXPERIMENTAL | INTERLEUKIN-1 | APOPTOSIS | ACTIVATED PROTEIN-C | PERINATAL INFLAMMATION | IL-1 RECEPTOR | CHRONIC LUNG-DISEASE | CELL BIOLOGY | EXTREME PRETERM BIRTH | INFANTS | TNF-ALPHA | HYALINE-MEMBRANE DISEASE | Interleukin 1 Receptor Antagonist Protein - administration & dosage | Inflammation - pathology | Bronchopulmonary Dysplasia - drug therapy | Humans | Bronchopulmonary Dysplasia - pathology | Infant | Inflammation - complications | Anti-Inflammatory Agents - adverse effects | Inflammation - drug therapy | Pulmonary Alveoli - drug effects | Anti-Inflammatory Agents - administration & dosage | Female | Infant, Newborn | Disease Models, Animal | Animals, Newborn | Lung - pathology | Pulmonary Alveoli - pathology | Bronchopulmonary Dysplasia - complications | Pregnancy | Animals | Lung - drug effects | Interleukin 1 Receptor Antagonist Protein - adverse effects | Protein C - administration & dosage | Mice | Protein C - adverse effects | Dysplasia | Interleukins | Anti-inflammatory drugs | Analysis | Protein C | Respiratory tract diseases | Infants | Medicine, Preventive | Enzyme-linked immunosorbent assay | Preventive health services | Brain | Therapy | Pediatrics | Cytokines | Interleukin 1 receptor antagonist | Lung diseases | Interleukin | Medical services | Histology | Inflammation | Interleukin 1 receptors | Macrophages | Babies | Interleukin 6 | Immunotherapy | Hyperoxia | Interleukin 1 | Alveoli | Macrophage inflammatory protein | Original
Journal Article
American Journal of Respiratory Cell and Molecular Biology, ISSN 1044-1549, 12/2016, Volume 55, Issue 6, pp. 858 - 868
Bronchopulmonary dysplasia (BPD) is a chronic disease of extreme prematurity that has serious long-term consequences including increased asthma risk. We... 
Bronchopulmonary dysplasia | Airway remodeling | IL-1 receptor antagonist | Precision-cut lung slice | Airway hyperresponsiveness | ADULT SURVIVORS | airway hyperresponsiveness | BIOCHEMISTRY & MOLECULAR BIOLOGY | airway remodeling | PRETERM BIRTH | NEONATAL HYPEROXIA EXPOSURE | LUNG ALVEOLARIZATION | bronchopulmonary dysplasia | HYPERRESPONSIVENESS | SUBEPITHELIAL FIBROSIS | CELL BIOLOGY | SMOOTH-MUSCLE | RESPIRATORY SYSTEM | INFLAMMATION | precision-cut lung slice | ASTHMA | EXPRESSION | Hyperoxia - physiopathology | Albuterol - pharmacology | Bronchopulmonary Dysplasia - pathology | Bronchopulmonary Dysplasia - physiopathology | Bronchial Hyperreactivity - physiopathology | Hyperoxia - complications | Hyperoxia - metabolism | Interleukin 1 Receptor Antagonist Protein - metabolism | Bronchial Hyperreactivity - metabolism | Female | Lung - metabolism | Disease Models, Animal | Lung - pathology | Pulmonary Alveoli - pathology | Mice, Inbred C57BL | Lung - physiopathology | Bronchial Hyperreactivity - complications | Bronchopulmonary Dysplasia - complications | Hyperoxia - pathology | Pregnancy | Bronchial Hyperreactivity - pathology | Animals | Muscle Contraction - drug effects | Bronchopulmonary Dysplasia - metabolism | Lung - drug effects | Airway Remodeling - drug effects | Muscle Relaxation - drug effects | Medical research | Intensive care | Dams | Cytokines | Lung diseases | Mortality | Histology | Inflammation | Inflammatory diseases | Asthma | Studies | Proteins | Lungs | Rodents | Hyperoxia
Journal Article
SCIENTIFIC REPORTS, ISSN 2045-2322, 10/2019, Volume 9, Issue 1, pp. 1 - 9
Journal Article
Arthritis and Rheumatology, ISSN 2326-5191, 12/2015, Volume 67, Issue 12, pp. 3219 - 3225
Objective. Knowledge of interleukin-38 (IL-38), formerly IL-1 family member 10, is sparse, but Il1f10 polymorphisms are associated with inflammatory diseases,... 
PATHOGENESIS | CLASSIFICATION | INDEX | MODEL | RHEUMATOLOGY | REVISED CRITERIA
Journal Article
Nature Immunology, ISSN 1529-2908, 03/2015, Volume 16, Issue 4, pp. 354 - 365
Interleukin 37 (IL-37) and IL-1R8 (SIGIRR or TIR8) are anti-inflammatory orphan members of the IL-1 ligand family and IL-1 receptor family, respectively. Here... 
CELLS | FAMILY-MEMBER | INFLAMMATION | TIR8/SIGIRR | INFECTION | IMMUNOLOGY | TOLL | INHIBITOR | EXPRESSION | NEGATIVE REGULATOR | MOLECULES | Inflammation - pathology | Interleukin-1 - genetics | RNA, Small Interfering - genetics | RNA-Binding Proteins - genetics | Humans | Receptors, Interleukin-1 - genetics | NF-kappa B - immunology | Receptor Protein-Tyrosine Kinases - immunology | Proto-Oncogene Proteins c-fyn - genetics | Signal Transduction - immunology | TOR Serine-Threonine Kinases - genetics | PTEN Phosphohydrolase - immunology | RNA, Small Interfering - immunology | Receptors, Interleukin-1 - deficiency | Leukocytes, Mononuclear - immunology | c-Mer Tyrosine Kinase | Interleukin-1 - immunology | Interleukin-18 Receptor alpha Subunit - genetics | Proto-Oncogene Proteins - immunology | Proto-Oncogene Proteins c-fyn - immunology | STAT3 Transcription Factor - genetics | Cell Line | PTEN Phosphohydrolase - genetics | Interleukin-18 Receptor alpha Subunit - immunology | Leukocytes, Mononuclear - drug effects | MAP Kinase Kinase Kinases - genetics | Receptors, Interleukin-1 - immunology | RNA-Binding Proteins - immunology | Gene Expression Regulation | Mice, Transgenic | Proto-Oncogene Proteins - genetics | Inflammation - immunology | Immunity, Innate | MAP Kinase Kinase Kinases - immunology | Interleukin-18 Receptor alpha Subunit - antagonists & inhibitors | Leukocytes, Mononuclear - pathology | TOR Serine-Threonine Kinases - immunology | Animals | NF-kappa B - genetics | Receptor Protein-Tyrosine Kinases - genetics | Lipopolysaccharides - pharmacology | Inflammation - genetics | Protein Binding | Mice | STAT3 Transcription Factor - immunology | Receptors, Interleukin-1 - antagonists & inhibitors
Journal Article
Journal of Translational Medicine, ISSN 1479-5876, 05/2017, Volume 15, Issue 1, pp. 92 - 16
Background: Patients with hereditary diffuse gastric cancer (HDGC), a cancer predisposition syndrome associated with germline mutations of the CDH1... 
C.1380delA CDH1 gastric cancer cells | Hereditary diffuse gastric cancer (HDGC) | Therapeutic leads | Differential gene expression profiling | High throughput drug screening | EPITHELIAL-MESENCHYMAL TRANSITION | BREAST-CANCER | MEDICINE, RESEARCH & EXPERIMENTAL | RESPONSES | ADHESION | c. 1380delA CDH1 gastric cancer cells | CYTOSKELETAL ORGANIZATION | CADHERIN MISSENSE MUTATIONS | Stomach Neoplasms - genetics | Genetic Predisposition to Disease | Reproducibility of Results | Humans | Gene Expression Regulation, Neoplastic | Male | Stomach Neoplasms - pathology | Up-Regulation - genetics | Gene Expression Profiling | Extracellular Signal-Regulated MAP Kinases - metabolism | Stomach Neoplasms - drug therapy | Germ-Line Mutation - genetics | High-Throughput Screening Assays | Diglycerides - metabolism | Pedigree | Cell Line, Tumor | Adult | Female | Cadherins - genetics | Drug Evaluation, Preclinical | Inositol Phosphates - metabolism | Cadherins - deficiency | TOR protein | Protein kinase C | Diacylglycerol | Cytotoxicity | Intracellular signalling | Genomes | Metastasis | Kinases | Drug screening | Cancer therapies | Stomach cancer | E-cadherin | Metastases | Cell adhesion & migration | Histopathology | Drug dosages | Gastric cancer | Inositol 1,4,5-trisphosphate | DNA topoisomerase (ATP-hydrolysing) | Extracellular signal-regulated kinase | MAP kinase | Rapamycin | Breast cancer | Tumor cell lines | Gene expression | Src protein | Patients | 1-Phosphatidylinositol 3-kinase | Inositols | Inhibitors | Mutation | Focal adhesion kinase | Apoptosis | c.1380delA CDH1 gastric cancer cells
Journal Article